Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Overweight 1Obesity 1Motor Activity 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Endometrial Neoplasms 1Disease 1Depressive Disorder 1Depression 1Carcinoma, Non-Small-Cell Lung 1

Interventions

luprolide acetate gel depot 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Leuprolide 2Goserelin 2Biopsy 2relugolix 1radium Ra 223 dichloride 1niraparib 1gallium 68 PSMA-11 1fluciclovine F-18 1flibanserin 1enzalutamide 1atezolizumab 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1X-Rays 1Triptorelin Pamoate 1Radium-223 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiosurgery 1Radiation 1Prednisone 1PROSTVAC 1Methods 1Lymph Node Excision 1Glutamate Carboxypeptidase II 1Estramustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Prostate Adenocarcinoma × Counseling × Clear all
NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
57 enrolled 27 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡